Rafael Franco

Universidad de León — Spain

Biochemistry, Genetics and Molecular Biology · Life Sciences

91h-index28.4kcitations633works6.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Receptor Mechanisms and Signaling(216), Adenosine and Purinergic Signaling(188), Neuroscience and Neuropharmacology Research(118), Neuropeptides and Animal Physiology(74), Cannabis and Cannabinoid Research(55)

Publications633 total

Theileriosis in Cattle
2026
The Heteromeric Dopamine Receptor D2:D3 Controls the Gut Recruitment and Suppressive Activity of Regulatory T-Cells
International Journal of Molecular Sciences·2025Open Access
Plasma p-tau217 in Alzheimer’s disease is a dynamic gauge of progression heterogeneity, not a baseline stratifier
Exploration of Neuroprotective Therapy·2025· 1 citedOpen Access
Cannabinoid CB<sub>1</sub> Receptor Activation Mitigates <i>N</i>-Methyl-<scp>d</scp>-aspartate Receptor-Mediated Neurotoxicity
ACS Pharmacology & Translational Science·2025· 1 citedOpen Access
The Heteromeric Dopamine Receptor D2:D3 Controls the Gut Recruitment and Suppressive Activity of Regulatory T-Cells
Preprints.org·2025Open Access
Machine Learning Approach to Select Small Compounds in Plasma as Predictors of Alzheimer’s Disease
International Journal of Molecular Sciences·2025· 1 citedOpen Access
First-in-Class SAM-Competitive G9a Inhibitor FLAV-27 as a Disease-Modifying Therapy for Alzheimer’s Disease
2025Open Access
Neuroprotective effects of G9a inhibition and cannabinoid receptor activation in Alzheimer's disease through a pharmacological approach
Neurotherapeutics·2025Open Access
Exposing Regional Disparities in Spain's Judiciary Civil Service Exams
2025Open Access
Novel protocol for metabolomics data normalization and biomarker discovery in human tears
Clinical Chemistry and Laboratory Medicine (CCLM)·2025· 2 citedOpen Access
Exposing Regional Disparities in Spain's Judiciary Civil Service Exams
2025Open Access
CE(20:4) and CE(22:5) cholesteryl ester levels are elevated in the plasma of Alzheimer’s disease patients with ε3/ε4 genotype
Exploration of Neuroprotective Therapy·2025· 2 citedOpen Access
Novel Soluble Epoxide Hydrolase Inhibitor: Toward Regulatory Preclinical Studies
ACS Pharmacology & Translational Science·2025· 4 citedOpen Access
GPR88 impairs the signaling of kappa opioid receptors in a heterologous system and in primary striatal neurons
Neuropharmacology·2024· 1 citedOpen Access
Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
npj Parkinson s Disease·2024· 5 citedOpen Access
307 - Correlation of Early Postpartum Anal/Faecal Incontinence with Endoanal Ultrasound, Digital Rectal Examination, Machine Learning-supported Electric Impedance Spectroscopy, and High-Resolution Anorectal Manometry Results: Exploratory Results from a Prospective, Comparative, Multicentre Clinical Study
Continence·2024Open Access
Progress on the development of Class A GPCR‐biased ligands
British Journal of Pharmacology·2024· 15 citedOpen Access
Olfactory receptors in neural regeneration in the central nervous system
Neural Regeneration Research·2024· 13 citedOpen Access
Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling
Pharmacological Research·2024· 83 citedOpen Access
The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson’s and Alzheimer’s Disease Progression
Cells·2024· 8 citedOpen Access
page 1 of 32Next →

Frequent Co-authors

Sergi Ferré(23), Vicent Casadó(17), Carme Lluı́s(17), Francisco Ciruela(15), Enric I. Canela(15), Kjell Fuxé(15), Josefa Mallol(14), Carmen Lluís(14), Luigi F. Agnati(10), Steven R. Goldberg(8), Meritxell Canals(7), Daniel Marcellino(7), Amina S. Woods(6), Javier Burgueño(5), Antoni Cortés(5), Estefanía Moreno(5), Maria Torvinen(4), Rodrigo Pacheco(4), Antonio Cortés(3), Jöelle Hillion(3)